Free Trial

Fortress Biotech (FBIO) Short Interest Ratio & Short Volume

Fortress Biotech logo
$1.57 -0.02 (-1.26%)
(As of 11/20/2024 ET)

Fortress Biotech Short Interest Data

Fortress Biotech (FBIO) has a short interest of 2.62 million shares, representing 11.97% of the float (the number of shares available for trading by the public). This marks a 1.95% increase in short interest from the previous month. The short interest ratio (days to cover) is 4.6, indicating that it would take 4.6 days of the average trading volume of 600,979 shares to cover all short positions.

Current Short Interest
2,620,000 shares
Previous Short Interest
2,570,000 shares
Change Vs. Previous Month
+1.95%
Dollar Volume Sold Short
$4.98 million
Short Interest Ratio
4.6 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
27,600,000 shares
Float Size
21,890,000 shares
Short Percent of Float
11.97%
Today's Trading Volume
376,835 shares
Average Trading Volume
600,979 shares
Today's Volume Vs. Average
63%
Short Selling Fortress Biotech?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Fortress Biotech and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

FBIO Short Interest Over Time

FBIO Days to Cover Over Time

FBIO Percentage of Float Shorted Over Time

Fortress Biotech Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/20242,620,000 shares $4.98 million +2.0%12.0%4.6 $1.90
10/15/20242,570,000 shares $4.42 million +9.4%11.7%5.2 $1.72
9/30/20242,350,000 shares $3.40 million +8.3%10.7%5 $1.45
9/15/20242,170,000 shares $4.27 million +26.2%12.1%5.9 $1.97
8/31/20241,720,000 shares $3.49 million +6.8%9.6%6.5 $2.03
8/15/20241,610,000 shares $3.06 million +1.3%9.5%6.6 $1.90
7/31/20241,590,000 shares $3.32 million +7.4%10.5%6.9 $2.09
7/15/20241,480,000 shares $2.96 million -10.8%9.7%7.4 $2.00
6/30/20241,660,000 shares $2.84 million +7.8%11.0%9.2 $1.71
6/15/20241,540,000 shares $2.88 million -4.4%10.2%7.9 $1.87
5/31/20241,610,000 shares $2.96 million -3.6%10.9%7.7 $1.84
5/15/20241,670,000 shares $2.91 million -4.6%11.5%6.8 $1.74
4/30/20241,750,000 shares $2.92 million -3.9%12.7%6.6 $1.67
4/15/20241,820,000 shares $3.31 million -3.2%13.0%6.1 $1.82
3/31/20241,880,000 shares $3.76 million +8.7%14.1%4.8 $2.00
3/15/20241,730,000 shares $3.35 million +12.3%13.0%3.5 $1.94
2/29/20241,540,000 shares $3.20 million -6.1%11.5%2.8 $2.08
2/15/20241,640,000 shares $3.08 million +10.1%12.3%2.8 $1.88
1/31/20241,490,000 shares $3.04 million +15.5%12.3%1.8 $2.04
1/15/20241,290,000 shares $2.48 million +14.2%10.6%1.6 $1.92
12/31/20231,130,000 shares $3.40 million +24.5%9.3%1.5 $3.01
12/15/2023907,400 shares $2.79 million +46.8%8.8%1.6 $3.07
11/30/2023618,000 shares $1.22 million +137.9%8.3%1.3 $1.98
11/15/2023259,800 shares $358,524.00 +52.9%3.5%0.7 $1.38
10/31/2023169,900 shares $304,121.00 +85.5%2.8%3 $1.79
10/15/202391,600 shares $265,640.00 +102.2%1.5%2 $2.90
9/30/202345,300 shares $197,258.85 -93.7%0.7%1.1 $4.35
9/15/2023715,100 shares $250,285.00 +0.6%0.8%1.2 $0.35
8/31/2023710,900 shares $248,815.00 +24.1%0.8%1.1 $0.35
8/15/2023572,800 shares $294,190.08 -15.2%0.6%0.9 $0.51
7/31/2023675,700 shares $385,149.00 +10.2%0.7%0.9 $0.57
7/15/2023613,200 shares $315,798.00 +13.5%0.7%0.9 $0.52
6/30/2023540,400 shares $297,220.00 +13.0%0.6%0.9 $0.55
6/15/2023478,400 shares $325,312.00 -44.8%0.5%0.8 $0.68
5/31/2023865,900 shares $465,854.20 +23.2%1.0%1.5 $0.54
5/15/2023702,900 shares $496,950.30 +6.8%0.8%1 $0.71
4/30/2023658,400 shares $504,992.80 -36.7%0.8%1.1 $0.77
4/15/20231,040,000 shares $842,296.00 -8.0%1.3%1.7 $0.81
3/31/20231,130,000 shares $926,600.00 +14.2%1.7%1.8 $0.82
3/15/2023989,200 shares $713,905.64 +200.9%1.4%1.4 $0.72
We recommended Nvidia in 2016, now we’re recommending this… (Ad)

The AI boom is just getting started. And the real wealth has still to be made…

You must read this new presentation from Porter Stansberry.
2/28/2023328,800 shares $253,176.00 -22.1%0.5%0.5 $0.77
2/15/2023422,000 shares $313,335.00 -3.7%0.7%0.8 $0.74
1/31/2023438,100 shares $398,671.00 +11.9%0.6%1 $0.91
1/15/2023391,700 shares $345,401.06 -51.3%0.5%1 $0.88
12/30/2022804,100 shares $526,685.50 +9.1%1.0%2.5 $0.66
12/15/2022737,400 shares $443,103.66 +10.9%0.9%3.5 $0.60
11/30/2022664,700 shares $439,566.11 +5.1%0.8%3.4 $0.66
11/15/2022632,600 shares $556,688.00 +4.5%0.8%3.6 $0.88
10/31/2022605,200 shares $502,376.52 +2.3%0.8%3.2 $0.83
10/15/2022591,400 shares $456,619.94 -20.9%0.7%2.6 $0.77
9/30/2022747,200 shares $642,592.00 +19.9%0.8%3.2 $0.86
9/15/2022623,400 shares $642,102.00 +0.1%0.7%1.3 $1.03
8/31/2022622,800 shares $635,256.00 -7.3%0.7%1.2 $1.02
8/15/2022671,600 shares $852,932.00 -2.3%0.7%1.1 $1.27
7/31/2022687,300 shares $591,490.38 -8.1%0.8%1 $0.86
7/15/2022748,100 shares $650,847.00 -25.9%0.8%1.1 $0.87
6/30/20221,010,000 shares $848,299.00 -69.8%3.1%1.3 $0.84
6/15/20223,340,000 shares $3.09 million +9.2%10.1%4.6 $0.93
5/31/20223,060,000 shares $2.64 million +3.0%3.6%5.1 $0.86
5/15/20222,970,000 shares $2.55 million +13.4%3.5%4.7 $0.86
4/30/20222,620,000 shares $2.88 million +42.4%3.1%4.4 $1.10
4/15/20221,840,000 shares $1.99 million +15.0%2.4%3.3 $1.08
3/31/20221,600,000 shares $2.18 million +2.6%2.2%3.3 $1.36
3/15/20221,560,000 shares $1.97 million +19.1%2.2%3.4 $1.26
2/28/20221,310,000 shares $2.11 million +18.0%1.9%2.8 $1.61
2/15/20221,110,000 shares $2.09 million +8.8%1.6%2.5 $1.88
1/31/20221,020,000 shares $2.13 million +16.8%1.5%2.4 $2.09
1/15/2022873,000 shares $2.02 million +1.9%1.3%2.1 $2.31
12/31/2021856,700 shares $2.14 million +16.5%1.2%2.1 $2.50
12/15/2021735,700 shares $1.93 million -22.5%1.1%1.1 $2.63
11/30/2021949,000 shares $2.70 million +10.9%1.4%1.6 $2.85
11/15/2021855,800 shares $2.88 million -18.5%1.2%1.5 $3.36
10/29/20211,050,000 shares $3.42 million -2.8%1.5%1.8 $3.26
10/15/20211,080,000 shares $3.33 million +39.8%1.5%1.9 $3.08
9/30/2021772,500 shares $2.49 million -16.7%1.1%1.4 $3.22
9/15/2021927,300 shares $3.07 million +17.3%1.3%2.7 $3.31
8/31/2021790,700 shares $2.60 million -18.4%1.1%1.7 $3.29
8/13/2021969,400 shares $2.99 million +2.2%1.4%1.8 $3.08
7/30/2021948,800 shares $2.95 million -6.1%1.4%1.6 $3.11
7/15/20211,010,000 shares $3.19 million -17.2%1.5%1.4 $3.16
6/30/20211,220,000 shares $4.36 million +8.9%1.8%1 $3.57
6/15/20211,120,000 shares $4.07 million -0.9%1.7%0.7 $3.63
5/28/20211,130,000 shares $4.55 million +10.8%1.7%0.7 $4.03
5/14/20211,020,000 shares $3.68 million +21.0%N/A0.5 $3.61
4/30/2021842,700 shares $3.66 million -52.1%N/A0.4 $4.34
4/15/20211,760,000 shares $7.64 million +46.7%2.8%0.9 $4.34
3/31/20211,200,000 shares $4.09 million -17.2%N/A0.7 $3.41
3/15/20211,450,000 shares $6.19 million +10.7%N/A1.5 $4.27
2/26/20211,310,000 shares $4.86 million +9.2%N/A1.3 $3.71
2/12/20211,200,000 shares $4.46 million -2.4%N/A1.6 $3.72
We recommended Nvidia in 2016, now we’re recommending this… (Ad)

The AI boom is just getting started. And the real wealth has still to be made…

You must read this new presentation from Porter Stansberry.
1/29/20211,230,000 shares $3.97 million -9.6%N/A1.6 $3.23
1/15/20211,360,000 shares $4.87 million -10.5%N/A1.6 $3.58
12/31/20201,520,000 shares $5.17 million -3.8%N/A1.5 $3.40
12/15/20201,580,000 shares $4.23 million +17.0%N/A1.4 $2.68
11/30/20201,350,000 shares $3.74 million -40.5%N/A1.1 $2.77
11/15/20202,270,000 shares $5.81 million -4.2%N/A1.6 $2.56
10/30/20202,370,000 shares $5.64 million +20.3%N/A1.5 $2.38
10/15/20201,970,000 shares $5.55 million -9.2%3.1%1.2 $2.82
9/30/20202,170,000 shares $8.77 million +6.9%3.4%1.5 $4.04
9/15/20202,030,000 shares $8.77 million +48.2%3.1%1.4 $4.32
8/31/20201,370,000 shares $5.41 million -8.7%2.1%1 $3.95
8/14/20201,500,000 shares $4.73 million -5.1%2.4%1.4 $3.15
7/31/20201,580,000 shares $4.39 million -2.5%2.7%1.9 $2.78
7/15/20201,620,000 shares $4.37 million -31.4%2.8%2 $2.70
6/30/20202,360,000 shares $6.28 million +337.9%4.0%3 $2.66
6/15/2020539,000 shares $1.49 million +17.3%0.9%0.8 $2.77
5/29/2020459,600 shares $1.35 million -28.4%0.8%0.8 $2.93
5/15/2020642,100 shares $1.65 million +31.4%1.1%1.2 $2.57
4/30/2020488,800 shares $992,264.00 -14.1%0.9%0.9 $2.03
4/15/2020569,000 shares $1.25 million -42.4%1.0%1.3 $2.20
3/31/2020987,900 shares $2.05 million +76.3%1.8%1.9 $2.08
3/13/2020560,500 shares $1.13 million -18.4%1.1%1.4 $2.02
2/28/2020687,000 shares $872,490.00 -15.6%1.4%1.5 $1.27
2/14/2020814,100 shares $1.41 million -4.9%1.7%1.8 $1.73
1/31/2020855,900 shares $1.97 million -18.5%1.7%2 $2.30
1/15/20201,050,000 shares $2.79 million -3.7%2.1%2.6 $2.66
12/31/20191,090,000 shares $2.84 million +64.2%2.2%3.3 $2.61

FBIO Short Interest - Frequently Asked Questions

What is Fortress Biotech's current short interest?

Short interest is the volume of Fortress Biotech shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 2,620,000 shares of FBIO short. 11.97% of Fortress Biotech's shares are currently sold short. Learn More on Fortress Biotech's current short interest.

What is a good short interest ratio for Fortress Biotech?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FBIO shares currently have a short interest ratio of 5.0. Learn More on Fortress Biotech's short interest ratio.

What is a good short interest percentage for Fortress Biotech?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.97% of Fortress Biotech's floating shares are currently sold short.

Is Fortress Biotech's short interest increasing or decreasing?

Fortress Biotech saw a increase in short interest in the month of October. As of October 31st, there was short interest totaling 2,620,000 shares, an increase of 1.9% from the previous total of 2,570,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Fortress Biotech's float size?

Fortress Biotech currently has issued a total of 27,600,000 shares. Some of Fortress Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Fortress Biotech currently has a public float of 21,890,000 shares.

How does Fortress Biotech's short interest compare to its competitors?

11.97% of Fortress Biotech's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Fortress Biotech: Chimerix, Inc. (1.90%), Verastem, Inc. (6.06%), Achieve Life Sciences, Inc. (9.65%), Regulus Therapeutics Inc. (3.19%), Agenus Inc. (13.16%), SAB Biotherapeutics, Inc. (0.79%), Curis, Inc. (1.84%), Bolt Biotherapeutics, Inc. (0.26%), Molecular Templates, Inc. (4.97%), Nature's Sunshine Products, Inc. (1.20%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Fortress Biotech stock?

Short selling FBIO is an investing strategy that aims to generate trading profit from Fortress Biotech as its price is falling. FBIO shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Fortress Biotech?

A short squeeze for Fortress Biotech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FBIO, which in turn drives the price of the stock up even further.

How often is Fortress Biotech's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FBIO, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:FBIO) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners